Professor of medicine and public health; associate vice chancellor for population health sciences
What is the best asthma treatment for African Americans?
How can we improve treatment of uncontrolled asthma in children visiting the emergency department?
How can we help patients stick to their treatment plans after they leave the hospital?
What can I do to reduce my risk of COVID-19?
These are just some of the questions Dr. Jerry Krishnan, professor of medicine and public health and associate vice president for population health sciences at UI Health, hopes to answer through several ongoing clinical studies.
Krishnan is a physician-scientist with expertise in the care of patients with asthma, chronic obstructive pulmonary disease and lung complications of COVID, including long COVID-19. He is a principal investigator of studies funded by the National Institutes of Health, the Patient-Centered Outcomes Research Institute, and the American Lung Association about how to prevent and treat lung disease. He is an expert in developing real-world evidence to guide patient care and health policy for people with chronic lung disease.
Krishnan was chairman of the Pulmonary-Allergy Drugs Advisory Committee for the U.S. Food and Drug Administration and previously served as a member of the National Committee for Quality Assurance Respiratory Measurement Advisory Panel, and the National Heart, Lung, and Blood Institute’s Clinical Trials Review Committee. He served on the guideline writing panel for the National Asthma Education and Prevention Program in 2020 and is on the Board of Directors for the Global Initiative for Asthma.
- Real-world evidence to support health care policy and population health
- Lung complications of COVID-19
- Long COVID-19 and Post-Acute Sequelae of SARS-CoV-2 infections (PASC)
- Chronic obstructive pulmonary disease (COPD)
- Clinical trials in chronic lung disease
- Evidence-based medicine and clinical guidelines
- Application of human-centered design to healthcare
- Respiratory health
- Public Health
In the News
March 31, 2022
November 18, 2020
May 9, 2019